Related topics

Arcturus Therapeutics: 2Q Earnings Snapshot

October 1, 2018

SAN DIEGO (AP) _ Arcturus Therapeutics (ARCT) on Monday reported a second-quarter loss of $10 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the San Diego-based company said it had a loss of 99 cents. Losses, adjusted for non-recurring costs, were 50 cents per share.

The pharmaceutical company posted revenue of $2.4 million in the period.

Arcturus Therapeutics shares have risen 11 percent since the beginning of the year. The stock has climbed 25 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT

Update hourly